Healthcare's Latest Prognosis
Emerging from a third-quarter pullback, healthcare companies are preparing for the next phase of the Affordable Care Act.
The initial phase of the Affordable Care Act focused on expanding access to healthcare for millions of Americans. Contentious debates aside--and one Supreme Court decision later--the ACA is now heading into its next phase, which will shift attention to improving the quality of care and, more important, reducing the costs of those services. This next phase promises to have profound implications on the healthcare industry, maybe even a bigger impact than the initial rollout.
This new stage of the law comes as healthcare stocks have struggled. A sell-off in late summer caused, in part, by concerns about an economic slowdown in China hit this sector particularly hard. Indeed, the $6 billion Vanguard Health Care ETF (VHT) is up 7% through October, but in the third quarter, it lost more than 12%.
Rob Wherry does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.